BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27966796)

  • 1. Identification of MSX1 and DCLK1 as mRNA Biomarkers for Colorectal Cancer Detection Through DNA Methylation Information.
    Sun AJ; Gao HB; Liu G; Ge HF; Ke ZP; Li S
    J Cell Physiol; 2017 Jul; 232(7):1879-1884. PubMed ID: 27966796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
    Zhang H; Dong S; Feng J
    J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The recently suggested intestinal cancer stem cell marker DCLK1 is an epigenetic biomarker for colorectal cancer.
    Vedeld HM; Skotheim RI; Lothe RA; Lind GE
    Epigenetics; 2014 Mar; 9(3):346-50. PubMed ID: 24384857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
    Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
    BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of PDX1, EN2, and MSX1 predicts the prognosis of colorectal cancer.
    Lee Y; Dho SH; Lee J; Hwang JH; Kim M; Choi WY; Lee JY; Lee J; Chang W; Lee MY; Choi J; Kim TY; Kim LK
    Exp Mol Med; 2022 Feb; 54(2):156-168. PubMed ID: 35169223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients.
    Mirzaei A; Tavoosidana G; Modarressi MH; Rad AA; Fazeli MS; Shirkoohi R; Tavakoli-Yaraki M; Madjd Z
    Tumour Biol; 2015 Jun; 36(6):4801-10. PubMed ID: 25631749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant promoter methylation of beta-1,4 galactosyltransferase 1 as potential cancer-specific biomarker of colorectal tumors.
    Poeta ML; Massi E; Parrella P; Pellegrini P; De Robertis M; Copetti M; Rabitti C; Perrone G; Muda AO; Molinari F; Zanellato E; Crippa S; Caputo D; Caricato M; Frattini M; Coppola R; Fazio VM
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1133-43. PubMed ID: 22927297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers.
    Vedeld HM; Andresen K; Eilertsen IA; Nesbakken A; Seruca R; Gladhaug IP; Thiis-Evensen E; Rognum TO; Boberg KM; Lind GE
    Int J Cancer; 2015 Feb; 136(4):844-53. PubMed ID: 24948044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly methylated genes in colorectal neoplasia: implications for screening.
    Zou H; Harrington JJ; Shire AM; Rego RL; Wang L; Campbell ME; Oberg AL; Ahlquist DA
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2686-96. PubMed ID: 18086775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Essential Role of DCLK1 in Pathogenesis, Diagnostic Procedures and Prognostic Stratification of Colorectal Cancer.
    Gzil A; Szylberg Ł; Jaworski D; Dominiak J; Zarębska I; Grzanka D
    Anticancer Res; 2019 Jun; 39(6):2689-2697. PubMed ID: 31177103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer.
    Kuhmann C; Li C; Kloor M; Salou M; Weigel C; Schmidt CR; Ng LW; Tsui WW; Leung SY; Yuen ST; Becker N; Weichenhan D; Plass C; Schmezer P; Chan TL; Popanda O
    Hum Mol Genet; 2014 Apr; 23(8):2043-54. PubMed ID: 24282031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer.
    Ichimura N; Shinjo K; An B; Shimizu Y; Yamao K; Ohka F; Katsushima K; Hatanaka A; Tojo M; Yamamoto E; Suzuki H; Ueda M; Kondo Y
    Cancer Prev Res (Phila); 2015 Aug; 8(8):702-11. PubMed ID: 26063725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel discriminating colorectal cancer model for differentiating normal and tumor tissues.
    Sun X; Tian Y; Zheng Q; Zheng R; Lin A; Chen T; Zhu Y; Lai M
    Epigenomics; 2018 Nov; 10(11):1463-1475. PubMed ID: 30324808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new insight into cancer stem cell markers: Could local and circulating cancer stem cell markers correlate in colorectal cancer?
    Mirzaei A; Tavoosidana G; Rad AA; Rezaei F; Tavakoli-Yaraki M; Kadijani AA; Khalili E; Madjd Z
    Tumour Biol; 2016 Feb; 37(2):2405-14. PubMed ID: 26383518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics data.
    Kok-Sin T; Mokhtar NM; Ali Hassan NZ; Sagap I; Mohamed Rose I; Harun R; Jamal R
    Oncol Rep; 2015 Jul; 34(1):22-32. PubMed ID: 25997610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups.
    Bond CE; Bettington ML; Pearson SA; McKeone DM; Leggett BA; Whitehall VL
    BMC Cancer; 2015 Jan; 15():20. PubMed ID: 25613750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification.
    Toyota M; Ho C; Ahuja N; Jair KW; Li Q; Ohe-Toyota M; Baylin SB; Issa JP
    Cancer Res; 1999 May; 59(10):2307-12. PubMed ID: 10344734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation markers in colorectal cancer.
    Kim MS; Lee J; Sidransky D
    Cancer Metastasis Rev; 2010 Mar; 29(1):181-206. PubMed ID: 20135198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer.
    Ide T; Kitajima Y; Ohtaka K; Mitsuno M; Nakafusa Y; Miyazaki K
    Oncol Rep; 2008 Jun; 19(6):1571-6. PubMed ID: 18497967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DCLK1, a promising colorectal cancer stem cell marker, regulates tumor progression and invasion through miR-137 and miR-15a dependent manner.
    Razi S; Sadeghi A; Asadi-Lari Z; Tam KJ; Kalantari E; Madjd Z
    Clin Exp Med; 2021 Feb; 21(1):139-147. PubMed ID: 32965580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.